SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-001169
Filing Date
2022-01-06
Accepted
2022-01-06 16:06:27
Documents
1
Period of Report
2022-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5450
  Complete submission text file 0000899243-22-001169.txt   6849
Mailing Address 175 WATER STREET NEW YORK NY 10038
Business Address
Dachille Douglas A. (Reporting) CIK: 0001652908 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 22514863

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations